GGrantIndex
Sort

10,766 grants matching checkpoint inhibitor

Epigenetic regulation of myeloid regulatory cell accumulation in the tumor microenvironment

$34,567
Alyssa Merting · Augusta University · F31 · FY2022 · CA

Intratumoral plasma cells in MPNST response to CDK4/6 targeted therapy and sensitization to immune checkpoint blockade

$34,491
Joshua J Lingo · University Of Iowa · F31 · FY2023 · CA

Identifying and targeting the genetic determinants of immune suppression and immunotherapy failure in prostate cancer.

$34,454
Katherine C. Murphy · Univ Of Massachusetts Med Sch Worcester · F31 · FY2025 · CA

The Role of Epithelial-Mesenchymal Transition in Re-Wiring KRAS Mutant Lung Cancer

$34,417
Don Lynn Gibbons · University Of Tx Md Anderson Can Ctr · R37 · FY2020 · CA

Role of cell-intrinsic effects of PD-L1 in carcinogenesis

$34,412
Anand Kornepati · University Of Texas Hlth Science Center · F30 · FY2020 · CA

Metabolic Reprogramming of Myeloid Cells to Enhance Cancer Immunotherapy

$34,356
Brian George Morreale · Roswell Park Cancer Institute Corp · F99 · FY2025 · CA

Function of NudC, a Novel Subtrate of Aurora B, in Spindle Checkpoint Activity

$34,272
Kimberly Nicole Weiderhold · Baylor College Of Medicine · F31 · FY2010 · GM

The Role of Mutant p53 in Regulating T-cell Immune Evasion in Pancreatic Adenocarcinoma and Other Cancers

$34,257
Deborah Ann Silverman · University Of Tx Md Anderson Can Ctr · F30 · FY2022 · CA

The Role of Glutamine Metabolism in Monocyte-Derived Dendritic Cell Differentiation in the Soft-Tissue Sarcoma Microenvironment

$34,191
Graham Lobel · University Of Pennsylvania · F30 · FY2022 · CA

Mechanisms underlying therapy failure of immune checkpoint inhibitors and Notch1 loss-mediated immunosuppression in head and neck cancers

$34,137
Rachel A Woolaver · University Of Colorado Denver · F31 · FY2019 · DE

Macrophage Ron signaling regulates the antitumor immune response in prostate cancer

$34,101
Camille Sullivan · University Of Cincinnati · F31 · FY2020 · CA

Function of NudC, a Novel Subtrate of Aurora B, in Spindle Checkpoint Activity

$34,068
Kimberly Nicole Weiderhold · Baylor College Of Medicine · F31 · FY2009 · GM

The Oncogenic functions of YAP/TAZ in Renal Cell Carcinoma

$34,052
Alec Thomas McIntosh · Georgetown University · F30 · FY2022 · CA

E2F AND THE CONTROL OF APOPTOSIS

$34,019
Ohio State University · R01 · FY2000 · CA

In vivo imaging of mitochondria structure and function in therapy resistant lung tumors

$33,990
David B Shackelford · University Of California Los Angeles · R01 · FY2024 · CA

Coordinating tumor differentiation and immune suppression with the metabolic state and treatment outcome

$33,932
Hans Ragnar Widlund · Brigham And Women'S Hospital · R01 · FY2021 · CA

ATM Controls Genomic Stability in Pluripotent Stem Cells

$33,872
Jason Mark Beckta · Virginia Commonwealth University · F30 · FY2014 · CA

Function of IRF8 in T cell activation and immune tolerance

$33,865
John David Klement · Augusta University · F30 · FY2022 · CA

Function of NudC, a Novel Subtrate of Aurora B, in Spindle Checkpoint Activity

$33,864
Kimberly Nicole Weiderhold · Baylor College Of Medicine · F31 · FY2008 · GM

Characterizing mechanisms and consequences of intergenic transcription in human cancers

$33,858
Vinayak Venkatasesha Viswanadham · Harvard Medical School · F31 · FY2021 · CA

Role of MYC Family Members in Driving Chemoresistance in Small Cell Lung Cancer

$33,650
Eli Grunblatt · University Of Washington · F30 · FY2020 · CA

Genomic and Microenvironmental Determinants, Temporal Dynamics, and Treatment Efficacy of Radiation-Based Combination Therapies

$33,602
Timothy An-Thy Chan · Cleveland Clinic Lerner Com-Cwru · U54 · FY2024 · CA

The Role of Tumor-Targeted TLR5 Activation in Reversing Immune Checkpoint Therapy Resistance

$33,541
Sarah E Glazer · University Of Tx Md Anderson Can Ctr · F30 · FY2021 · CA

The Role of Mutant p53 in Regulating T-cell Immune Evasion in Pancreatic Adenocarcinoma and Other Cancers

$33,541
Deborah Ann Silverman · University Of Tx Md Anderson Can Ctr · F30 · FY2021 · CA

ATM Controls Genomic Stability in Pluripotent Stem Cells

$33,428
Jason Mark Beckta · Virginia Commonwealth University · F30 · FY2013 · CA